Welcome to the Fajgenbaum Lab, where we work to form a better understanding of Castleman Disease & other Cytokine Storm Disorders
We are recruiting for multiple positions at the CSTL! Check out our current positions here
The Center for Cytokine Storm Treatment & Laboratory (CSTL) [pronounced “Castle”] is dedicated to investigating hyperinflammation and immune system dysregulation in the context of human disease. To gain insight into these types of disorders, our group conducts research with the goal of improving the diagnosis, treatment, and management of Castleman Disease, a rare hyperinflammatory disorder. Our group is unique in that instead of focusing on one experimental technique, or subfield, our lab uses multiple techniques and technologies to study Castleman disease (and other hyperinflammatory disorders) from multiple angles. To fulfill this goal, the CSTL recruits scientists with diverse backgrounds and expertise, including basic bench research, biobanking, and data analysis.
Our interests include:
Elucidating the etiology, dysregulated cell types, signaling pathways, and effector cytokines in idiopathic multicentric Castleman disease (iMCD) and related cytokine storm disorders
Identifying effective treatments for iMCD patients
PI3K/Akt/mTOR signaling in iMCD
Understanding the role of stromal cells and chemokines in iMCD.
Our research projects are divided into five broad categories:
Defining CD and its clinico-pathology
Etiology of CD
Pathophysiology
Treatment effectiveness studies
Rare-disease sample acquisition methodologies
-
Meet the Team
We are an interdisciplinary mix of clinical data analysts, cell biologists, lab technicians, physicians, and data scientists.
-
Our Research
We utilize a number of technologies and techniques to answer questions about Castleman Disease and other cytokine storm disorders.
-
Keep Up With Recent News in the Lab
With so many moving pieces, it’s often difficult to keep up with everything going on in our Center!
-
Join us
Interested in joining the CSTL? See what positions/opportunities we currently have available!